CompanyGraph
Focus Minerals Limited
FML · ASX · Australia
Price data from its FML listing on CXA
focusminerals.com.auFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $42.94M, above the global median of $16.24M
- PositionProfit margin is 90.4%, higher than 95% of its Gold peers (median 11.7%)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
627.56MAUD450.59M · vs all stocks (USD)
Trailing P/E
8.10xvs Gold peers
Revenue (TTM)
301.26MAUD216.31M · vs all stocks (USD)
Profit Margin
90.44%vs Gold peers
Beta
1.63xvs all stocks
52-Week Change
403.45%vs all stocks
Market Capitalization
627.56MAUD450.59M · vs all stocks (USD)
Enterprise Value
439.18MAUD315.33M · vs all stocks (USD)
Trailing P/E
8.10xvs Gold peers
Price to Sales (TTM)
1.85xvs Gold peers
Price to Book (MRQ)
1.51xvs Gold peers
Enterprise to Revenue
1.46xvs Gold peers
Enterprise to EBITDA
3.12xvs Gold peers
Profit Margin
90.44%vs Gold peers
Operating Margin
39.52%vs Gold peers
Return on Assets (TTM)
16.04%vs Gold peers
Return on Equity (TTM)
29.73%vs Gold peers
Revenue (TTM)
301.26MAUD216.31M · vs all stocks (USD)
Revenue per Share (TTM)
1.05AUDUpdated Aug 21, 2026Quarterly Revenue Growth
202.40%vs Gold peers
Gross Profit (TTM)
194.63MAUD139.74M · vs all stocks (USD)
EBITDA (TTM)
136.43MAUD97.96M · vs all stocks (USD)
Net Income (TTM)
68.92MAUD49.49M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
783.10%vs Gold peers
Operating Cash Flow (TTM)
130.93MAUD94.01M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
59.81MAUD42.94M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00AUDUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Gold peers
Revenue
301.26MAUDFY2025 · Dec 31, 2025Cost of Goods Sold
-7.75MAUDFY2025 · Dec 31, 2025Gross Profit
309.02MAUDFY2025 · Dec 31, 2025Operating Income
89.45MAUD64.23M · vs all stocks (USD)
Pre-tax Income
83.67MAUDFY2025 · Dec 31, 2025Income Tax Expense
14.75MAUDFY2025 · Dec 31, 2025Net Income
272.45MAUDFY2025 · Dec 31, 2025EBIT
88.13MAUDFY2025 · Dec 31, 2025EBITDA (Income Statement)
136.43MAUDFY2025 · Dec 31, 2025Selling, General & Administrative
40.25MAUDFY2025 · Dec 31, 2025Other Operating Expenses
131.86MAUDFY2025 · Dec 31, 2025Non-operating Interest Income
2.54MAUDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.46MAUDFY2025 · Dec 31, 2025EPS (Basic)
0.9508AUDFY2025 · Dec 31, 2025EPS (Diluted)
0.9508AUDFY2025 · Dec 31, 2025Basic Shares Outstanding
286.56MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
286.56MSharesFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
129.81MAUDFY2025 · Dec 31, 2025Interest Paid
12.44MAUDFY2025 · Dec 31, 2025Capital Expenditures
-10.50MAUDFY2025 · Dec 31, 2025Net Acquisitions
246.34MAUDFY2025 · Dec 31, 2025Purchase of Investments
-29.88MAUDFY2025 · Dec 31, 2025Net Investing Cash Flow
205.97MAUDFY2025 · Dec 31, 2025Long-term Debt Issuance
15.92MAUDFY2025 · Dec 31, 2025Long-term Debt Payments
-165.01MAUDFY2025 · Dec 31, 2025Other Financing Charges
-4.94MAUDFY2025 · Dec 31, 2025Net Financing Cash Flow
-154.02MAUDFY2025 · Dec 31, 2025Shares Outstanding
286.56MSharesUpdated Aug 21, 2026Float Shares
84.46MSharesUpdated Aug 21, 2026% Held by Insiders
69.35%vs all stocks
% Held by Institutions
1.04%vs all stocks
Total Cash (MRQ)
129.81MAUD93.21M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4530AUDUpdated Aug 21, 2026Total Debt (MRQ)
4.47MAUD3.21M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0122xvs Gold peers
Current Ratio (MRQ)
4.09xvs Gold peers
Book Value per Share (MRQ)
1.28AUDUpdated Aug 21, 2026Total Assets
442.73MAUD317.88M · vs all stocks (USD)
Total Current Assets
194.79MAUDFY2025 · Dec 31, 2025Total Liabilities
74.65MAUDFY2025 · Dec 31, 2025Total Non-current Assets
247.94MAUDFY2025 · Dec 31, 2025Total Non-current Liabilities
26.98MAUDFY2025 · Dec 31, 2025Total Current Liabilities
47.67MAUDFY2025 · Dec 31, 2025Cash
129.81MAUDFY2025 · Dec 31, 2025Cash & Cash Equivalents
129.81MAUDFY2025 · Dec 31, 2025Other Short-term Investments
29.89MAUDFY2025 · Dec 31, 2025Accounts Receivable
2.24MAUDFY2025 · Dec 31, 2025Inventory
17.24MAUDFY2025 · Dec 31, 2025Accounts Payable
28.40MAUDFY2025 · Dec 31, 2025Short-term Debt
2.69MAUDFY2025 · Dec 31, 2025Deferred Revenue
14.75MAUDFY2025 · Dec 31, 2025Long-term Debt
1.78MAUDFY2025 · Dec 31, 2025Common Stock (Book)
453.12MAUDFY2025 · Dec 31, 2025Retained Earnings
-85.04MAUDFY2025 · Dec 31, 2025Total Shareholders' Equity
368.07MAUD264.28M · vs all stocks (USD)
52-Week Low
0.4300AUDUpdated Aug 21, 202652-Week High
4.45AUDUpdated Aug 21, 202652-Week Change
403.45%vs all stocks
Beta
1.63xvs all stocks
50-Day MA
1.78AUDUpdated Aug 21, 2026200-Day MA
2.64AUDUpdated Aug 21, 2026Avg 10-Day Volume
253.87KSharesUpdated Aug 21, 2026Avg 30-Day Volume
224.54KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.2400AUDUpdated Aug 21, 2026Other Income / Expense
-3.36MAUDFY2025 · Dec 31, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 90.4%, higher than 95% of its Gold peers (median 11.7%)Significant
Profit margin: 0.90Industry median: 0.12Industry P95: 0.59Peers compared: 58.00
Financial Health
Altman Z-Score 5.23: safe zoneNotable
Altman Z-Score: 5.23
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $42.94M, above the global median of $16.24MNotable
Levered free cash flow (USD): 42,941,426Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Galiano Gold Inc.
Tier 1ProductionDepleting ExtractiveFlowRule
Idaho Strategic Resources, Inc.
Tier 1ProductionDepleting ExtractiveFlowRule
Asante Gold Corporation
Tier 1ProductionDepleting ExtractiveFlowRisk
AltynGold plc
Tier 1ProductionDepleting ExtractiveFlowRisk
Deep Industries Limited
Tier 1ProductionDepleting ExtractiveFlowRisk
Yunnan Jinggu Forestry Co., Ltd.
Tier 1ProductionDepleting ExtractiveFlowRule
Nouveau Monde Graphite Inc.
Tier 1ProductionDepleting ExtractiveFlowRisk
Sichuan Shengda Forestry Industry Co. Ltd.
Tier 1ProductionDepleting ExtractiveFlowRule
Tivan Limited
Tier 1ProductionDepleting ExtractiveRuleSenseMaking
Suzhou Chunxing Precision Mechanical Co., Ltd.
Tier 1ProductionDepleting ExtractiveFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Sk Biopharmaceuticals Co., Ltd.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMinimal Tax and Interest DragROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
XD Inc.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMinimal Tax and Interest DragROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated
Rigel Pharmaceuticals, Inc.
6 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMinimal Tax and Interest DragROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsThree Asset-Base Ratios Elevated